(Q52218975)

27 April 2018

title

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. (English)

1 reference

27 April 2018

0 references

1 reference

1 reference

1

Szczeklik A

1 reference

27 April 2018

3

Undas A

1 reference

27 April 2018

author name string

Musiał J

2

1 reference

27 April 2018

Gajewski P

4

1 reference

27 April 2018

Góra P

5

1 reference

27 April 2018

Swadźba J

6

1 reference

27 April 2018

Jankowski M

7

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 April 1999

1 reference

27 April 2018

Journal of the American College of Cardiology

published in

1 reference

27 April 2018

volume

33

1 reference

27 April 2018

issue

5

1 reference

27 April 2018

page(s)

1286-1293

1 reference

27 April 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Increased thromboxane biosynthesis in type IIa hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Platelet-dependent thrombin generation in patients with hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Cholesterol management in theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900023-6

7 January 2021

10.1016/S0735-1097(99)00023-6

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018